SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-021084
Filing Date
2024-01-31
Accepted
2024-01-31 17:19:00
Documents
18
Period of Report
2024-01-30
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d752729d8k.htm   iXBRL 8-K 30655
2 EX-1.1 d752729dex11.htm EX-1.1 226725
3 EX-4.1 d752729dex41.htm EX-4.1 67464
4 EX-5.1 d752729dex51.htm EX-5.1 12725
8 GRAPHIC g752729g0131011016866.jpg GRAPHIC 2534
  Complete submission text file 0001193125-24-021084.txt   548701

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA pcvx-20240130.xsd EX-101.SCH 2849
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE pcvx-20240130_lab.xml EX-101.LAB 17993
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pcvx-20240130_pre.xml EX-101.PRE 11260
19 EXTRACTED XBRL INSTANCE DOCUMENT d752729d8k_htm.xml XML 3630
Mailing Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070
Business Address 825 INDUSTRIAL ROAD, STE. 300 SAN CARLOS CA 94070 650-837-0111
Vaxcyte, Inc. (Filer) CIK: 0001649094 (see all company filings)

IRS No.: 464233385 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39323 | Film No.: 24583965
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)